DK627987A - Farmaceutiske praeparater - Google Patents

Farmaceutiske praeparater

Info

Publication number
DK627987A
DK627987A DK627987A DK627987A DK627987A DK 627987 A DK627987 A DK 627987A DK 627987 A DK627987 A DK 627987A DK 627987 A DK627987 A DK 627987A DK 627987 A DK627987 A DK 627987A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
interferon
pro
chem
simultaneous
Prior art date
Application number
DK627987A
Other languages
English (en)
Other versions
DK627987D0 (da
DK166715B1 (da
Inventor
Martin Cole
Malcolm Richard Boyd
David Sutton
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of DK627987D0 publication Critical patent/DK627987D0/da
Publication of DK627987A publication Critical patent/DK627987A/da
Application granted granted Critical
Publication of DK166715B1 publication Critical patent/DK166715B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
DK627987A 1986-12-02 1987-11-30 Farmaceutiske produkt og anvendelse af dette til fremstilling af et kombinationspraeparat til behandling af virusinfektioner DK166715B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628826A GB8628826D0 (en) 1986-12-02 1986-12-02 Pharmaceutical products
GB8628826 1986-12-02

Publications (3)

Publication Number Publication Date
DK627987D0 DK627987D0 (da) 1987-11-30
DK627987A true DK627987A (da) 1988-06-03
DK166715B1 DK166715B1 (da) 1993-07-05

Family

ID=10608331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK627987A DK166715B1 (da) 1986-12-02 1987-11-30 Farmaceutiske produkt og anvendelse af dette til fremstilling af et kombinationspraeparat til behandling af virusinfektioner

Country Status (16)

Country Link
US (1) US4957733A (da)
EP (1) EP0271270B1 (da)
JP (1) JP2724711B2 (da)
KR (1) KR960000432B1 (da)
AT (1) ATE74011T1 (da)
AU (1) AU606629B2 (da)
CA (1) CA1318850C (da)
DE (1) DE3777769D1 (da)
DK (1) DK166715B1 (da)
ES (1) ES2037095T3 (da)
GB (1) GB8628826D0 (da)
GR (1) GR3004487T3 (da)
IE (1) IE59943B1 (da)
NZ (1) NZ222741A (da)
PT (1) PT86232B (da)
ZA (1) ZA878983B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
EP0405315B1 (en) * 1989-06-30 1995-08-23 American Cyanamid Company Use of a phagocyte-activating agent : LPS or IL-2 for the manufacture of a medicament for treating staphylococcus aureus infection in cows
JPH03124960A (ja) * 1989-10-11 1991-05-28 Mitsubishi Electric Corp 同軸形スタータ装置
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9615111D0 (en) * 1996-07-18 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
AU5127098A (en) * 1996-11-29 1998-06-22 Smithkline Beecham Plc Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
US6165458A (en) * 1997-12-26 2000-12-26 Pharmaderm Laboratories Ltd. Composition and method for dermal and transdermal administration of a cytokine
EP1655813A1 (de) * 2004-11-09 2006-05-10 Phoenix Contact GmbH & Co. KG Befestigung für elektrische Verbindung
AU2006230269A1 (en) 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition

Also Published As

Publication number Publication date
KR880007080A (ko) 1988-08-26
PT86232A (en) 1987-12-01
DE3777769D1 (de) 1992-04-30
CA1318850C (en) 1993-06-08
EP0271270B1 (en) 1992-03-25
EP0271270A3 (en) 1989-09-27
ATE74011T1 (de) 1992-04-15
ES2037095T3 (es) 1993-06-16
GB8628826D0 (en) 1987-01-07
NZ222741A (en) 1990-10-26
JPS63145279A (ja) 1988-06-17
DK627987D0 (da) 1987-11-30
GR3004487T3 (da) 1993-03-31
IE873247L (en) 1988-06-02
EP0271270A2 (en) 1988-06-15
AU8191287A (en) 1988-06-02
DK166715B1 (da) 1993-07-05
AU606629B2 (en) 1991-02-14
ZA878983B (en) 1988-08-31
PT86232B (pt) 1990-11-07
KR960000432B1 (ko) 1996-01-06
US4957733A (en) 1990-09-18
IE59943B1 (en) 1994-05-04
JP2724711B2 (ja) 1998-03-09

Similar Documents

Publication Publication Date Title
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
DK627987D0 (da) Farmaceutiske praeparater
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
ZA901572B (en) Pharmaceutical treatment
AU566974B2 (en) Pharmaceutical preparations containing a phospholipidan an oxicam derivative
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
IT8740155A0 (it) Estensione dell'uso di un prodotto farmaceutico alimentare curativo
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
FI935388A0 (fi) Menetelmä lääkeaineena käyttökelpoisen bentsimidatsolidipyridiniumjohdannaisten valmistamiseksi
ES551388A0 (es) Procedimiento de preparacion de derivados 3,5-diamino-1h-1,2,4-triazoles y de sales de adicion acida farmaceuticamente aceptables de los mismos
NO883663L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired